FIT, Proton Therapy System will help advance precision cancer care. Fortis Healthcare, part of the IHH Healthcare group, ...
India’s central drug regulator has flagged select batches of seven medicines as spurious and declared 167 other samples “not of standard quality” (NSQ) in its routine surveillance for December 2025, ...
The 650,000 sq ft campus will accommodate over 5,000 professionals working on innovative health technologies Royal Philips announced the launch of an innovation campus in Yelahanka, Bengaluru. The 650 ...
A new study led by the Indian Council of Medical Research (ICMR) has revealed that women suffering from metabolic syndrome (MeS) face a significantly higher risk of developing gynaecological cancers, ...
US drugmaker AbbVie has entered India’s cancer market with its oral blood cancer drug Venetoclax, aiming to offer new treatment options for leukaemia patients, according to AbbVie’s announcement on ...
Dr Reddy’s Laboratories has announced its entry into the trade generics business in India with the launch of its new dedicated division ‘RGenX’. Through this, Dr Reddy’s aims to provide patients with ...
Committed to bridging the gap, the legion of health tech start ups have risen to advance healthcare services across the country. These new age start ups are proving to be a beacon of hope to millions, ...
Intas Pharmaceuticals, one of India’s leading pharmaceutical companies with operations across the globe has launched TOFATAS – a DCGI-approved, Tofacitinib Ointment 2 per cent w/w for the treatment of ...
Medanta has launched a Mediclinic at Subhash Chowk in Gurugram. Medanta Mediclinic was inuagurated by Dr Naresh Trehan, CMD, Medanta, Pankaj Sahni, Group CEO, Medanta, and Dr Sushila Kataria, Director ...
India’s first homegrown CAR-T cancer therapy has achieved a rare combination – financial sustainability and wider patient access – pushing the country to the frontlines of global cell and gene therapy ...
As employers confront rising burnout, low engagement with preventive care, and generational divides in health behaviour, ekincare is leveraging AI, personalization, and integrated services to reshape ...
To manufacture and market Galvus and Galvus combination brands, used in the treatment of type 2 diabetes from January 1, 2026 Cipla has signed a perpetual license agreement with Novartis Pharma ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results